We are live on ! Find out more
NFT

Nan Fung Trinity Portfolio holdings

AUM $1.01B
1-Year Est. Return 64.38%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+64.38%
3 Year Est. Return
+82.31%
5 Year Est. Return
+69.52%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$260M
Cap. Flow
+$231M
Cap. Flow %
18.28%
Top 10 Hldgs %
34.47%
Holding
89
New
18
Increased
31
Reduced
4
Closed
11

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$33.3M
2
KT icon
KT
KT
+$27.8M
3
AMD icon
Advanced Micro Devices
AMD
+$19.9M
4
MP icon
MP Materials
MP
+$17.9M
5
UNH icon
UnitedHealth
UNH
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.24%
2 Technology 15.47%
3 Communication Services 13.78%
4 Consumer Discretionary 10.13%
5 Materials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKR icon
51
Acadia Realty Trust
AKR
$3.09B
$9.41M 0.75%
458,100
TGT icon
52
Target
TGT
$65.6B
$8.53M 0.68%
87,300
+23,300
+36% +$2.15M
BBIO icon
53
BridgeBio Pharma
BBIO
$15.7B
$8.42M 0.67%
+110,100
New +$7.23M
BXP icon
54
Boston Properties
BXP
$11.2B
$8.23M 0.65%
121,924
+30,700
+34% +$2.18M
CELC icon
55
Celcuity
CELC
$4.21B
$8.06M 0.64%
+80,775
New +$6.64M
KRC icon
56
Kilroy Realty
KRC
$4.52B
$7.88M 0.62%
210,800
+133,400
+172% +$5.45M
PCVX icon
57
Vaxcyte
PCVX
$7.81B
$6.59M 0.52%
142,930
+38,680
+37% +$1.73M
FRT icon
58
Federal Realty Investment Trust
FRT
$10.7B
$6.45M 0.51%
64,000
BCAX
59
Bicara Therapeutics
BCAX
$1.78B
$6.27M 0.5%
372,385
-12,500
-3% -$213K
SLG icon
60
SL Green Realty
SLG
$3.76B
$6.23M 0.49%
+135,823
New +$6.71M
SLNO
61
DELISTED
Soleno Therapeutics
SLNO
$5.73M 0.45%
123,850
REPL icon
62
Replimune Group
REPL
$941M
$5.59M 0.44%
575,527
+110,000
+24% +$935K
ESRT icon
63
Empire State Realty Trust
ESRT
$872M
$5.22M 0.41%
801,300
ABEO icon
64
Abeona Therapeutics
ABEO
$366M
$5.04M 0.4%
956,770
+396,000
+71% +$1.99M
VNO icon
65
Vornado Realty Trust
VNO
$7.41B
$4.79M 0.38%
143,800
+45,700
+47% +$1.67M
ZLAB icon
66
Zai Lab
ZLAB
$2.06B
$4.76M 0.38%
269,975
BAH icon
67
Booz Allen Hamilton
BAH
$8.39B
$4.18M 0.33%
49,500
AVTX icon
68
Avalo Therapeutics
AVTX
$965M
$3.43M 0.27%
+189,000
New +$3.19M
QURE icon
69
uniQure
QURE
$3.03B
$2.76M 0.22%
+115,494
New +$4.46M
DOC icon
70
Healthpeak Properties
DOC
$15.1B
$2.65M 0.21%
+165,064
New +$2.91M
KALV
71
DELISTED
KalVista Pharmaceuticals
KALV
$2.5M 0.2%
154,522
IDV icon
72
iShares International Select Dividend ETF
IDV
$8.45B
$2.11M 0.17%
53,500
+26,500
+98% +$1M
SPYD icon
73
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$1.97M 0.16%
45,600
+23,300
+104% +$1.01M
CLYM
74
Climb Bio
CLYM
$681M
$1.85M 0.15%
463,654
GERN icon
75
Geron
GERN
$828M
$1.81M 0.14%
1,373,550

Similar funds

Nan Fung Trinity's Q4 2025 Portfolio in Review

As of Q4 2025, Nan Fung Trinity held 89 positions worth $1.26B, up 26% from $1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nan Fung Trinity deployed $231M of net new capital in Q4 2025, opening 18 new positions and adding to 31 existing holdings. Its largest new stake was iShares MBS ETF: 349,200 shares worth $33.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.

  • Nan Fung Trinity's largest Q4 2025 buy was iShares MBS ETF: 349,200 shares worth $33.3M.
  • Nan Fung Trinity added most to Advanced Micro Devices in Q4 2025, an estimated $19.9M increase.
  • Nan Fung Trinity's biggest Q4 2025 reduction was Intel, cutting an estimated $10.6M.
  • Nan Fung Trinity fully exited State Street SPDR S&P Regional Banking ETF in Q4 2025, selling an estimated $33.7M.
  • Nan Fung Trinity's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2025.
  • Nan Fung Trinity opened 18 new positions and closed 11 in Q4 2025.
  • Nan Fung Trinity's portfolio value rose 26% quarter-over-quarter to $1.26B.

Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.